Aridis Pharmaceuticals (NASDAQ:ARDS) Stock Rating Lowered by Zacks Investment Research – TechNewsObserver
Aridis Pharmaceuticals (NASDAQ:ARDS) Stock Rating Lowered by Zacks Investment Research TechNewsObserver
Aridis Pharmaceuticals (NASDAQ:ARDS) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued to …
Source: Investment New Feed